Researchers evaluated the effects of solriamfetol on driving performance in patients with excessive daytime sleepiness and obstructive sleep apnea.
Snoring is associated with increased risk of cerebral events in patients with obstructive sleep apnea and established cardiovascular disease.
Patients with obstructive or central sleep apnea experienced improvements in apnea-hypopnea index following treatment with acetazolamide.
The burden of both objective and subjective obstructive sleep apnea improved more in patients who received upper airway stimulation compared with those who did not.
Sleep-disordered breathing and fragmented sleep are associated with higher levels of fasting glucose and hemoglobin A1c in black adults.
VA and DoD joint guideline addresses sleep disorders in military personnel and veterans.
Atomoxetine plus oxybutynin demonstrated efficacy in improving upper airway collapsibility, increasing breathing stability, and reducing the threshold for arousal in obstructive sleep apnea.
One of the most common symptoms of obstructive sleep apnea is excessive daytime sleepiness, which is why it is often confused with narcolepsy.
The study expands on prior research by incorporating a larger more diverse CKD/ESRD population followed over a longer period, and it adjusted for several important confounders, such as kidney transplant status.
Beneficiaries with OSA also demonstrate higher annual costs across all points of service.
